Veronick Benoy

1.4k total citations
16 papers, 805 citations indexed

About

Veronick Benoy is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Veronick Benoy has authored 16 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Oncology. Recurrent topics in Veronick Benoy's work include Histone Deacetylase Inhibitors Research (9 papers), Peptidase Inhibition and Analysis (6 papers) and Signaling Pathways in Disease (4 papers). Veronick Benoy is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Peptidase Inhibition and Analysis (6 papers) and Signaling Pathways in Disease (4 papers). Veronick Benoy collaborates with scholars based in Belgium, United States and United Kingdom. Veronick Benoy's co-authors include Ludo Van Den Bosch, Lawrence Van Helleputte, Robert Prior, Peter Vangheluwe, Alan P. Kozikowski, Wanda Haeck, Pieter Vanden Berghe, Philip Van Damme, Wim Robberecht and Constantin d’Ydewalle and has published in prestigious journals such as Nature, Brain and Chemical Communications.

In The Last Decade

Veronick Benoy

16 papers receiving 799 citations

Peers

Countries citing papers authored by Veronick Benoy

Since Specialization

Citations

This map shows the geographic impact of Veronick Benoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronick Benoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronick Benoy more than expected).

Fields of papers citing papers by Veronick Benoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veronick Benoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronick Benoy. The network helps show where Veronick Benoy may publish in the future.

Co-authorship network of co-authors of Veronick Benoy

This figure shows the co-authorship network connecting the top 25 collaborators of Veronick Benoy. A scholar is included among the top collaborators of Veronick Benoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veronick Benoy. Veronick Benoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot–Marie–Tooth Type 2A Mouse Model 2021 ·Journal of Medicinal Chemistry ·Sida Shen, Cristina Picci, (unknown), Veronick Benoy, Zsófia Kutil, Guiping Zhang, Maurício T. Tavares, Jiřı́ Pavlı́ček, Chad Zimprich, Matthew B. Robers, Ludo Van Den Bosch, Cyril Bařinka, Brett Langley, Alan P. Kozikowski	20
2	ATP13A2 deficiency disrupts lysosomal polyamine export 2020 ·Nature ·Sarah van Veen, Shaun Martin, Chris Van den Haute, Veronick Benoy, Joseph A. Lyons, Roeland Vanhoutte, Jan Kähler, Jean-Paul Decuypere, Géraldine Gelders, Eric J. Lambie, Jeffrey Zielich, Johannes V. Swinnen, Wim Annaert, Patrizia Agostinis, Bart Ghesquière, Steven H. L. Verhelst, Veerle Baekelandt, Jan Eggermont, Peter Vangheluwe	216
3	Primary Active Ca²⁺ Transport Systems in Health and Disease 2019 ·Cold Spring Harbor Perspectives in Biology ·Jialin Chen, (unknown), Veronick Benoy, M. Rosario Sepúlveda, Peter Vangheluwe	60
4	Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome 2018 ·ACS Chemical Neuroscience ·Alan P. Kozikowski, Sida Shen, Marta Pardo, Maurício T. Tavares, (unknown), Veronick Benoy, Chad Zimprich, Zsófia Kutil, Guiping Zhang, Cyril Bařinka, Matthew B. Robers, Ludo Van Den Bosch, James H. Eubanks, Richard S. Jope	58
5	Defective axonal transport: A common pathological mechanism in inherited and acquired peripheral neuropathies 2017 ·Neurobiology of Disease ·Robert Prior, Lawrence Van Helleputte, Veronick Benoy, Ludo Van Den Bosch	81
6	HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease 2017 ·Brain ·Veronick Benoy, Lawrence Van Helleputte, Robert Prior, Constantin d’Ydewalle, Wanda Haeck, (unknown), Wendy Scheveneels, (unknown), M. Zameel Cader, Kevin Talbot, Alan P. Kozikowski, Pieter Vanden Berghe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch	98
7	Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease 2016 ·Neurotherapeutics ·Veronick Benoy, Pieter Vanden Berghe, Matthew Jarpe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch	69
8	THE ROLE OF HISTONE DEACETYLASE 6 (HDAC6) IN MUTANT GLYCYL-TRNA SYNTHETASE (GARS) AND MUTANT SMALL HEAT SHOCK PROTEIN B1 (HSPB1)-INDUCED AXONAL CHARCOT-MARIE-TOOTH DISEASE (CMT) 2016 ·Veronick Benoy, (unknown), (unknown), M. Zameel Cader, (unknown), Alan P. Kozikowski, Albena Jordanova, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch	1
9	Synthesis and SAR assessment of novel Tubathian analogs in the pursuit of potent and selective HDAC6 inhibitors 2016 ·Organic & Biomolecular Chemistry ·Rob De Vreese, (unknown), Tom Verhaeghe, Tom Desmet, Veronick Benoy, Wanda Haeck, Ludo Van Den Bosch, Matthias D’hooghe	24
10	Synthesis of Potent and Selective HDAC6 Inhibitors Bearing a Cyclohexane‐ or Cycloheptane‐Annulated 1,5‐Benzothiazepine Scaffold 2016 ·Chemistry - A European Journal ·Rob De Vreese, (unknown), (unknown), Jorick Franceus, Tom Desmet, Kristof Van Hecke, Veronick Benoy, Ludo Van Den Bosch, Matthias D’hooghe	30
11	Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot–Marie–Tooth Disease 2015 ·ACS Chemical Neuroscience ·Sida Shen, Veronick Benoy, Joel Bergman, Jay H. Kalin, (unknown), Giulio Vistoli, Wanda Haeck, Ludo Van Den Bosch, Alan P. Kozikowski	64
12	Neuropathological findings from a human post mortem case of distal hereditary motor neuropathy (dHMN) due to p.Ser135Phe HSPB1 mutation and transgenic mice with mutant or wild-type HSP27 overexpression 2015 ·Neuromuscular Disorders ·Rahul Phadke, Alexander M. Rossor, Veronick Benoy, Bernadett Kalmár, R. H. M. King, Linda Greensmith, Ludo Van Den Bosch, Mary M. Reilly, Henry Houlden	1
13	Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors 2015 ·Chemical Communications ·Rob De Vreese, (unknown), Tom Verhaeghe, Tom Desmet, Nadia Bougarne, Karolien De Bosscher, Veronick Benoy, Wanda Haeck, Ludo Van Den Bosch, Matthias D’hooghe	28
14	The Trpa1 Agonist Cinnamaldehyde Acts as a Local Anesthetic Inhibiting Voltage-Gated Sodium Channels in Sensory Neurons 2014 ·Biophysical Journal ·Brett Boonen, Yeranddy A. Alpízar, Veronick Benoy, Ludo Van Den Bosch, Thomas Voets, Karel Talavera	3
15	The role of histone deacetylase 6 (HDAC6) in neurodegeneration 2014 ·Lirias (KU Leuven) ·Lawrence Van Helleputte, Veronick Benoy, Ludo Van Den Bosch	23
16	Charcot-Marie-Tooth disease: Emerging mechanisms and therapies 2012 ·The International Journal of Biochemistry & Cell Biology ·Constantin d’Ydewalle, Veronick Benoy, Ludo Van Den Bosch	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact